Cargando…
A Review of Potential Therapeutic Strategies for COVID-19
Coronavirus disease 2019 is a rather heterogeneous disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The ongoing pandemic is a global threat with increasing death tolls worldwide. SARS-CoV-2 belongs to lineage B β-CoV, a subgroup of Sarbecovirus. These enveloped, large,...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696587/ https://www.ncbi.nlm.nih.gov/pubmed/36366444 http://dx.doi.org/10.3390/v14112346 |
_version_ | 1784838347345100800 |
---|---|
author | Meng, Jiajia Li, Ruijiao Zhang, Zhiqi Wang, Jie Huang, Qingwen Nie, Dongxia Fan, Kai Guo, Wenbo Zhao, Zhihui Han, Zheng |
author_facet | Meng, Jiajia Li, Ruijiao Zhang, Zhiqi Wang, Jie Huang, Qingwen Nie, Dongxia Fan, Kai Guo, Wenbo Zhao, Zhihui Han, Zheng |
author_sort | Meng, Jiajia |
collection | PubMed |
description | Coronavirus disease 2019 is a rather heterogeneous disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The ongoing pandemic is a global threat with increasing death tolls worldwide. SARS-CoV-2 belongs to lineage B β-CoV, a subgroup of Sarbecovirus. These enveloped, large, positive-sense single-stranded RNA viruses are easily spread among individuals, mainly via the respiratory system and droplets. Although the disease has been gradually controlled in many countries, once social restrictions are relaxed the virus may rebound, leading to a more severe and uncontrollable situation again, as occurred in Shanghai, China, in 2022. The current global health threat calls for the urgent development of effective therapeutic options for the treatment and prevention of SARS-CoV-2 infection. This systematic overview of possible SARS-CoV-2 therapeutic strategies from 2019 to 2022 indicates three potential targets: virus entry, virus replication, and the immune system. The information provided in this review will aid the development of more potent and specific antiviral compounds. |
format | Online Article Text |
id | pubmed-9696587 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96965872022-11-26 A Review of Potential Therapeutic Strategies for COVID-19 Meng, Jiajia Li, Ruijiao Zhang, Zhiqi Wang, Jie Huang, Qingwen Nie, Dongxia Fan, Kai Guo, Wenbo Zhao, Zhihui Han, Zheng Viruses Review Coronavirus disease 2019 is a rather heterogeneous disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The ongoing pandemic is a global threat with increasing death tolls worldwide. SARS-CoV-2 belongs to lineage B β-CoV, a subgroup of Sarbecovirus. These enveloped, large, positive-sense single-stranded RNA viruses are easily spread among individuals, mainly via the respiratory system and droplets. Although the disease has been gradually controlled in many countries, once social restrictions are relaxed the virus may rebound, leading to a more severe and uncontrollable situation again, as occurred in Shanghai, China, in 2022. The current global health threat calls for the urgent development of effective therapeutic options for the treatment and prevention of SARS-CoV-2 infection. This systematic overview of possible SARS-CoV-2 therapeutic strategies from 2019 to 2022 indicates three potential targets: virus entry, virus replication, and the immune system. The information provided in this review will aid the development of more potent and specific antiviral compounds. MDPI 2022-10-25 /pmc/articles/PMC9696587/ /pubmed/36366444 http://dx.doi.org/10.3390/v14112346 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Meng, Jiajia Li, Ruijiao Zhang, Zhiqi Wang, Jie Huang, Qingwen Nie, Dongxia Fan, Kai Guo, Wenbo Zhao, Zhihui Han, Zheng A Review of Potential Therapeutic Strategies for COVID-19 |
title | A Review of Potential Therapeutic Strategies for COVID-19 |
title_full | A Review of Potential Therapeutic Strategies for COVID-19 |
title_fullStr | A Review of Potential Therapeutic Strategies for COVID-19 |
title_full_unstemmed | A Review of Potential Therapeutic Strategies for COVID-19 |
title_short | A Review of Potential Therapeutic Strategies for COVID-19 |
title_sort | review of potential therapeutic strategies for covid-19 |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696587/ https://www.ncbi.nlm.nih.gov/pubmed/36366444 http://dx.doi.org/10.3390/v14112346 |
work_keys_str_mv | AT mengjiajia areviewofpotentialtherapeuticstrategiesforcovid19 AT liruijiao areviewofpotentialtherapeuticstrategiesforcovid19 AT zhangzhiqi areviewofpotentialtherapeuticstrategiesforcovid19 AT wangjie areviewofpotentialtherapeuticstrategiesforcovid19 AT huangqingwen areviewofpotentialtherapeuticstrategiesforcovid19 AT niedongxia areviewofpotentialtherapeuticstrategiesforcovid19 AT fankai areviewofpotentialtherapeuticstrategiesforcovid19 AT guowenbo areviewofpotentialtherapeuticstrategiesforcovid19 AT zhaozhihui areviewofpotentialtherapeuticstrategiesforcovid19 AT hanzheng areviewofpotentialtherapeuticstrategiesforcovid19 AT mengjiajia reviewofpotentialtherapeuticstrategiesforcovid19 AT liruijiao reviewofpotentialtherapeuticstrategiesforcovid19 AT zhangzhiqi reviewofpotentialtherapeuticstrategiesforcovid19 AT wangjie reviewofpotentialtherapeuticstrategiesforcovid19 AT huangqingwen reviewofpotentialtherapeuticstrategiesforcovid19 AT niedongxia reviewofpotentialtherapeuticstrategiesforcovid19 AT fankai reviewofpotentialtherapeuticstrategiesforcovid19 AT guowenbo reviewofpotentialtherapeuticstrategiesforcovid19 AT zhaozhihui reviewofpotentialtherapeuticstrategiesforcovid19 AT hanzheng reviewofpotentialtherapeuticstrategiesforcovid19 |